当前位置:首页 - 行情中心 - 华绿生物(300970) - 财务分析 - 现金流量表

华绿生物

(300970)

  

流通市值:21.80亿  总市值:28.18亿
流通股本:1.24亿   总股本:1.60亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金692,925,793.36407,608,253.491,293,926,393.33863,621,727.41
  收到的税费返还---69.8
  收到其他与经营活动有关的现金19,580,701.4210,998,874.7333,168,000.4321,707,575.47
  经营活动现金流入小计712,506,494.78418,607,128.221,327,094,393.76885,329,372.68
  购买商品、接受劳务支付的现金420,903,204.41205,630,518.99753,257,806.32538,137,851.84
  支付给职工以及为职工支付的现金111,994,590.3961,131,160.58202,354,909.06150,440,153.79
  支付的各项税费615,543.36261,554.18846,076.77587,116.36
  支付其他与经营活动有关的现金13,623,197.565,343,961.1425,327,959.0630,413,345.89
  经营活动现金流出小计547,136,535.72272,367,194.89981,786,751.21719,578,467.88
  经营活动产生的现金流量净额165,369,959.06146,239,933.33345,307,642.55165,750,904.8
二、投资活动产生的现金流量:
  收回投资收到的现金210,000,000---
  取得投资收益收到的现金248,986.31---
  处置固定资产、无形资产和其他长期资产收回的现金净额35,91632,00089,470.7289,470.72
  处置子公司及其他营业单位收到的现金净额---0
  收到的其他与投资活动有关的现金---16,165,920
  投资活动现金流入小计210,284,902.3132,00089,470.7216,255,390.72
  购建固定资产、无形资产和其他长期资产支付的现金50,345,890.5535,007,721.26123,118,056.1282,112,396.36
  投资支付的现金210,000,000---
  支付其他与投资活动有关的现金---0
  投资活动现金流出小计260,345,890.5535,007,721.26123,118,056.1282,112,396.36
  投资活动产生的现金流量净额-50,060,988.24-34,975,721.26-123,028,585.4-65,857,005.64
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,500,000-25,759,5880
  取得借款收到的现金8,670,0008,670,000149,471,531.89144,541,531.89
  筹资活动现金流入小计11,170,0008,670,000175,231,119.89144,541,531.89
  偿还债务支付的现金43,573,573-151,149,787.17120,036,979.56
  分配股利、利润或偿付利息支付的现金65,931,907.772,639,662.9412,590,471.588,487,621.88
  其中:子公司支付给少数股东的股利、利润--1,053,621.14-
  支付其他与筹资活动有关的现金17,578,772.5312,374,820.554,714,157.26-
  筹资活动现金流出小计127,084,253.315,014,483.49168,454,416.01128,524,601.44
  筹资活动产生的现金流量净额-115,914,253.3-6,344,483.496,776,703.8816,016,930.45
五、现金及现金等价物净增加额-605,282.48104,919,728.58229,055,761.03115,910,829.61
  加:期初现金及现金等价物余额588,638,447.03588,638,447.03359,582,686359,582,686
  期末现金及现金等价物余额588,033,164.55693,558,175.61588,638,447.03475,493,515.61
补充资料:
  净利润55,798,995.69-119,255,767.97-
  资产减值准备8,111,086.05--151,765.13-
  固定资产和投资性房地产折旧82,255,318.6-164,053,157.96-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧82,255,318.6-164,053,157.96-
  无形资产摊销926,827.57-1,853,655.18-
  长期待摊费用摊销--37,499.87-
  处置固定资产、无形资产和其他长期资产的损失-102,977.56-2,147,494.3-
  固定资产报废损失190,159.2-554,859.93-
  财务费用10,541,376.9-15,970,456.41-
  投资损失-248,986.31---
  存货的减少-29,598,683.26--28,928,301.59-
  经营性应收项目的减少-5,162,957.01-3,303,657.89-
  经营性应付项目的增加15,677,908.28-33,063,783.75-
  其他--80,456.62-
  融资租入固定资产--5,500,351.21-
  现金的期末余额588,033,164.55-588,638,447.03-
  减:现金的期初余额588,638,447.03-359,582,686-
  现金及现金等价物的净增加额-605,282.48-229,055,761.03-
公告日期2026-08-202026-04-222026-04-222025-10-24
审计意见(境内)标准无保留意见
TOP↑